Mirae Asset Global Investments Co., Ltd. Ngm Biopharmaceuticals Inc Transaction History

Mirae Asset Global Investments Co., Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$1.17 - $1.92 $24,767 - $40,644	21,169 New	21,169 $33,000
Q2 2023 Aug 10, 2023	SELL	$2.44 - $4.53 $395 - $733	-162 Reduced 0.7%	23,031 $59,000
Q1 2023 May 04, 2023	SELL	$3.72 - $5.4 $163 - $237	-44 Reduced 0.19%	23,193 $94,000
Q4 2022 Feb 09, 2023	BUY	$3.41 - $12.93 $211 - $801	62 Added 0.27%	23,237 $116,000
Q3 2022 Nov 10, 2022	BUY	$12.59 - $17.67 $153,610 - $215,591	12,201 Added 111.18%	23,175 $303,000
Q2 2022 Jul 26, 2022	BUY	$10.58 - $17.5 $116,104 - $192,045	10,974 New	10,974 $141,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.